SEC 13F Intelligence

Endurant Capital Management LP / AZNN

Endurant Capital Management LP’s Astrazeneca PLC Position

Does Endurant Capital Management LP own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 96.4K shares worth $7M in Q3 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$7M
Q3 2023
Shares
96.4K
% of Portfolio
+5.87%
Quarters Held
11
position exited

Position History AZNN

Reported value by quarter
Q2 ’19: $5MQ2 ’19Q3 ’19: $1MQ4 ’20: $3MQ4 ’20Q1 ’21: $12MQ4 ’21: $19MQ4 ’21Q1 ’22: $16MQ3 ’22: $6MQ3 ’22Q4 ’22: $10MQ1 ’23: $7MQ1 ’23Q2 ’23: $4MQ3 ’23: $7MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202396.4K$7M+5.87%
Q2 202360.8K$4M+3.80%
Q1 202397.3K$7M+3.47%
Q4 2022141.4K$10M+3.89%
Q3 2022101.0K$6M+1.80%
Q1 2022240.3K$16M+4.20%
Q4 2021324.7K$19M+4.57%
Q1 2021238.1K$12M+3.09%
Q4 202056.9K$3M+1.03%
Q3 201931.0K$1M+0.50%
Q2 2019124.9K$5M+2.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of AZNN.